Status:
RECRUITING
Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System
Lead Sponsor:
Marmara University
Conditions:
Levonorgestrel Adverse Reaction
Temporomandibular Joint Disorders
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate the possible role of levonorgestrel intrauterine system use(LIU) in the pathogenesis of temporomandibular joint disorder (TMD). In this clinical trial...
Eligibility Criteria
Inclusion
- Being a woman
- Having used an intrauterine device for at least 3 months
- Being between the ages of 18-50
- Being in American Society of Anesthesiologists-1 and American Society of Anesthesiologists-2 systemic status
Exclusion
- Patients with craniofacial syndrome
- Patients with a history of head and neck trauma
- Isolated muscle tenderness or previous surgery on TMJ
- Patients with rheumatological disorders
- Patients with an additional gynecological disease other than endometriosis
- Lack of cooperation with the patient.
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06500390
Start Date
January 15 2024
End Date
December 15 2024
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University
Istanbul, Maltepe, Turkey (Türkiye), 34854